Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 2,542 | 2,118 | 764 | -2 | 18 |
| Cost of Goods | 2,343 | 1,937 | 687 | 4 | 8 |
| Gross Profit | 199 | 181 | 77 | -6 | 10 |
| Operating Expenses | 1,041 | 1,883 | 1,914 | 1,538 | 312 |
| Operating Income | -499 | -765 | -1,150 | -1,540 | -294 |
| Interest Expense | 62 | 80 | 61 | 58 | 53 |
| Other Income | -38 | -71 | 2 | 104 | 43 |
| Pre-tax Income | -599 | -916 | -1,210 | -1,495 | -303 |
| Income Tax | 0 | 0 | 0 | -2 | 2 |
| Net Income Continuous | -599 | -916 | -1,210 | -1,493 | -305 |
| Minority Interests | -9 | -29 | -8 | -26 | 5 |
| Net Income | $-590 | $-887 | $-1,201 | $-1,463 | $-311 |
| EPS Basic Total Ops | -0.05 | -0.07 | -0.12 | -0.15 | -0.04 |
| EPS Basic Continuous Ops | -0.05 | -0.07 | -0.12 | -0.16 | -0.04 |
| EPS Diluted Total Ops | -0.05 | -0.07 | -0.12 | -0.15 | -0.04 |
| EPS Diluted Continuous Ops | -0.05 | -0.07 | -0.12 | -0.16 | -0.04 |
| EBITDA(a) | $-345 | $-610 | $-1,001 | $-1,273 | $-146 |